GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
Since May 2020, federal efforts to speed the development, manufacturing, and distribution of COVID-19 vaccines—previously known as Operation Warp Speed—have been led by the Departments of Health and Human Services and Defense.
The VA allows eligible veterans to receive care from community providers when they face challenges accessing care at VA medical facilities. The VA is still responsible for ensuring that these community providers are qualified and competent.
The Substance Abuse and Mental Health Services Administration (SAMHSA) administers the State Opioid Response Grant program for opioid use disorder prevention, treatment, and recovery services.
SAMHSA assesses the program through 2 annual performance reports.
The Defense Production Act allows federal agencies to require companies to prioritize government contracts for medical supplies to address national emergencies, like COVID-19. Federal agencies have used DPA authorities to expand production of COVID-related medical supplies.
The COVID-19 pandemic increased social isolation and stress—affecting the behavioral health of many Americans. Data suggests higher rates of anxiety and depression symptoms, and more substance use among many adults, as a result.
The Office of National Drug Control Policy (ONDCP) coordinates the nation's drug control policy. ONDCP's responsibilities include tracking and publicizing information about federal grants that fund drug control activities, such as prevention and treatment.
The National Institutes of Health's duties include researching infectious diseases and administering over $30 billion a year in research grants. NIH uses IT systems containing sensitive data to carry out its mission.
This report is a public version of our June 2021 report on NIH cybersecurity.